PU researchers convert agri waste into edible sugars
June 28, 2021
LAHORE:A research team under Punjab University Centre for Research in Ionic Liquids (CRIL) Director Dr Maliha Uroos has developed a protocol to convert agricultural waste into food.
The food grade glucose produced can be used for human consumption, in pharmaceuticals, general food industry and for the production of artificial proteins. The CRIL has been recently established by PU VC Prof Dr Niaz Ahmed Akhtar with an aim to resolve socio-economic problems.
The work is published in international journal of American Chemical Society named “ACS Sustainable Chemistry & Engineering” with an impact factor of 7.63. This research contribution was made possible by her PhD student Azmat Mehmood Asim, in collaboration with Prof Jason Hallett, Imperial College London and Dr Nawshad Muhammad, Khyber Medical University.
A company founded at Imperial is set to scale-up its innovative method for producing sustainable biochemicals, materials and fuels.
Lixea has closed a €2 million investment from the European Innovation Council Fund (EIC Fund) pilot. The investment complements the previous EIC grant of €2.3 million as part of the European Commission’s support to scale and commercialise the Lixea technology.
The associate deputy minister said the delay is partially related to ensuring members of the public have fair and equitable access to participate. Some people have had mostly normal lives in the last year during the pandemic, but that’s not the case for everyone.
European funding boost for Imperial clean-tech spinout Lixea | Imperial News imperial.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imperial.ac.uk Daily Mail and Mail on Sunday newspapers.
Share
Most vaccines require refrigeration to keep from going bad. The messenger RNA vaccines for COVID-19 require freezing temperatures. RONNY HARTMANN/AFP via Getty Images
Here’s how scientists are designing vaccines that can ditch the fridge
Apr. 21, 2021 , 3:30 PM
From the cutting-edge vaccines for COVID-19 to the decades-old ones for poliovirus, most vaccines need to be kept cold to survive the trip from factory to patient. But that poses a major hurdle to even routine immunizations in countries like Mali or Bangladesh, where up to 90% of health facilities lack adequate refrigeration. To solve this problem, some researchers are working toward a radical goal: vaccine formulations that don’t have to be kept cold. Significant hurdles remain, but many scientists are optimistic that 10 years from now vaccination campaigns won’t be quite so hampered by the heat.